共 142 条
[1]
Kumar P(2011)Ovarian hyperstimulation syndrome J Hum Reprod Sci. 4 70-5
[2]
Sait SF(2012)Cabergoline for preventing ovarian hyperstimulation syndrome Cochrane Database Syst Rev. 15 CD008605-208
[3]
Sharma A(2002)Human chorionic gonadotropin (HCG) activates monocytes to produce IL-8 via a different pathway from luteinizing hormone (LH)/HCG receptor system J Clin Endocrinol Metab 87 5199-51
[4]
Kumar M(2007)Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome Hum Reprod. 22 1647-51
[5]
Tang H(2009)Symposium: update on prediction and management of OHSS. Prevention of OHSS--dopamine agonists Reprod Biomed Online 19 43-75
[6]
Hunter T(2014)Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials Fertil Steril. 101 664-74
[7]
Hu Y(2013)Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis Hum Fertil (Camb) 16 168-7
[8]
Zhai SD(2006)Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome Hum Reprod 21 2830-9
[9]
Sheng X(2007)A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS Reprod Biomed Online. 15 271-7
[10]
Hart RJ(2009)Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series Fertil Steril 92 1169.e15-62